Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients

This study has been terminated.
(In January, 2013 Merck had decided to take steps to suspend the availability of TREDAPTIVE globally)
Sponsor:
Information provided by (Responsible Party):
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT01052311
First received: January 16, 2010
Last updated: April 21, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)